Parkinson disease (PD) is the second most common neurodegenerative disorder, affecting>
1% of the population≥ 65 years of age and with a prevalence set to double by 2030. In …

Mild cognitive impairment associated with Parkinson's disease (PD) is a risk factor for the
development of dementia. Despite the importance of early identification of mild cognitive …

People with Parkinson's disease (PD) and their care partners frequently report cognitive
decline as one of their greatest concerns. Mild cognitive impairment affects approximately 20 …

Dementia can occur in a substantial number of patients with Parkinson's disease with a point
prevalence close to 30%. The cognitive profile is characterized by predominant deficits in …

Cognitive impairment is common in PD, even in early stages. The construct of mild cognitive
impairment has been used to identify clinically evident cognitive impairment without …

Abstract Introduction In PD, Mild Cognitive Impairment (PD-MCI) occurs since early stages of
disease. The aims were to assess presence of PD-MCI in untreated, drug-naive PD patients …

ABSTRACT Background The International Parkinson and Movement Disorder Society
criteria for mild cognitive impairment in PD were recently formulated. Objectives The aim of …

The impact of Parkinson's disease (PD) dementia is substantial and has major functional
and socioeconomic consequences. Early prediction of future cognitive impairment would …

Mild cognitive changes, including executive dysfunction, are seen in Parkinson's Disease
(PD). Approximately 30% of individuals with PD develop Parkinson's disease dementia …

Approximately 30% of Parkinson's disease (PD) patients show impaired cognitive
performance, which is suggestive of Mild Cognitive Impairment (MCI), representing a …